Skip to content
GLP-1 Scorecard
Menu

Site position #72

Harmon.Health

Published by GLP-1 ScorecardUpdated

Harmon.Health sells compounded semaglutide and tirzepatide at one price for every dose, plus dissolving tablets and the brand Wegovy pill, but its site links to no published terms.

Semaglutide
$149/mo (month-to-month; $389 billed quarterly or $1,249 yearly, same price at every dose, compounded)
Tirzepatide
$199/mo (month-to-month; $499 billed quarterly or $1,599 yearly, same price at every dose, compounded)
Coverage
All states except Mississippi
Brand-name
Yes
In this review
Visit Harmon.HealthWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Weigh Harmon.Health against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives before comparing prices. The trial evidence behind the drugs themselves is in our research library, kept separate from these grades. Every listing is graded on the same six factors as this one.

If the price or terms here do not fit, our Eden review and our Sesame Care review set out the prices, renewal terms and what we could not verify for each. Both sellers pay us a commission when a reader signs up, which never changes a grade.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value83/100
Dose & formulation96/100
Clinical oversight68/100
Labs & monitoring51/100
Fulfillment70/100
Contract terms55/100

Strengths

  • Same price at every dose, with quarterly and yearly plans
  • Offers injections, dissolving tablets and the brand Wegovy pill
  • Serves every state except Mississippi

What to consider

  • The Terms of Service, telehealth consent and privacy notice links in the footer lead nowhere
  • Neither the prescribing physicians nor the pharmacies are named
  • Introductory prices run until December 1, 2026, and some prices depend on a separate club membership

Bottom line — Grade C

Best for: Price-focused buyers who want a flat compounded price and will read the terms at checkout before paying.

Site position #72 of 515. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Harmon.Health — the realistic shortlist.

The 22 rankings nearest this one

View full scorecard rankings →

Prices and terms can change; confirm them with Harmon.Health. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard